S. 4469 · 118th Congress · Health
Chronic Kidney Disease Improvement in Research and Treatment Act of 2024
- IntroducedJun 5, 2024 Done
- CommitteeDied Jan 3, 2025 Stopped here
- Senate floorNot yet Not reached yet
- House floorNot yet Not reached yet
- Chambers agreeNot yet Not reached yet
- PresidentNot yet Not reached yet
What it does
The Congressional Research Service hasn’t published a summary of this bill. Read the full text on Congress.gov.Who lobbies on it
3 organizations · 9 filings · Q2 2024–Q4 2024One square per quarter since introduction, oldest left. Filled = named it that quarter.
-
Fresenius Medical Care North America
3 of 3 quarters
“Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 6860/S. 5018, the Restore Protections for Dialysis Patients Act; H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Treatment Act of 2023; H.R. 5074/S. 4510, Kidney PATIENT Act of 2023; H.R. 10545, American Relief Act…”
$6.5M lobbying spend in 2024, all issuesQ4 2024 filing
-
Davita Inc
3 of 3 quarters
“…S. 4469, Chronic Kidney Disease Improvement in Research and Treatment Act”
$4.2M lobbying spend in 2024, all issuesQ4 2024 filing
-
Akebia Therapeutics, Inc.
3 of 3 quarters
“H.R. 4366, Consolidated Appropriations Act of 2024, including provisions relating to health care H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Treatment Act of 2023 H.R. 6860, Restore Protections for Dialysis Patients Act H.R. 7085, BIOSECURE Act S. 3558, to prohibit contracting with certain…”
$1.1M lobbying spend in 2024, all issuesQ4 2024 filing
Organizations that named S. 4469 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.
Actions
2 actions · newest first- Jun 5, 2024Read twice and referred to the Committee on Finance.
- Jun 5, 2024Introduced in Senate